Clinical predictors of recurrent Clostridium difficile infection in out-patients

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 5, 2014, Pages 518-522

  Shivashankar, R ^a   Khanna, S ^a   Kammer, P P ^a   Scott Harmsen, W ^a   Zinsmeister, A R ^a   Baddour, L M ^a   Pardi, D S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DNA, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84905822445     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12864     Document Type: Article

References (22)

1. Kelly CP, LaMont JT,. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-40.
2. Hu MY, Katchar K, Kyne L, et al,. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009; 136: 1206-14.
3. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN,. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999; 20: 43-50.
4. Kyne L, Kelly CP,. Recurrent Clostridium difficile diarrhoea. Gut 2001; 49: 152-3.
5. Maroo S, Lamont JT,. Recurrent clostridium difficile. Gastroenterology 2006; 130: 1311-6.
6. Khanna S, Pardi DS, Aronson SL, et al,. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012; 107: 89-95.
7. Johnson S,. Meeting the challenge of recurrent Clostridium difficile infection. J Hosp Med 2012; 7 (Suppl. 3): S11-3.
8. Cohen SH, Gerding DN, Johnson S, et al,. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
9. Mattila E, Arkkila P, Mattila PS, Tarkka E, Tissari P, Anttila VJ,. Rifaximin in the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2013; 37: 122-8.
10. Choi HK, Kim KH, Lee SH, Lee SJ,. Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization. J Korean Med Sci 2011; 26: 859-64.
11. Garey KW, Sethi S, Yadav Y, DuPont HL,. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008; 70: 298-304.
12. Feuerstadt P, Das R, Brandt LJ,. Diverticular disease of the colon does not increase risk of repeat C. difficile infection. J Clin Gastroenterol 2013; 47 (5): 426-31.
13. Khanna S, Pardi DS,. Clostridium difficile infection: new insights into management. Mayo Clin Proc 2012; 87: 1106-17.
14. Kim YG, Graham DY, Jang BI,. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol 2012; 46: 397-400.
15. Khanna S, Pardi DS, Rosenblatt JE, Patel R, Kammer PP, Baddour LM,. An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol 2012; 46 (10): 846-9.
16. Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW, Han M,. Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology 2010; 76: 553-7.
17. Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ,. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther 2009; 29: 626-34.
18. Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F,. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis 2007; 9: 173-7.
19. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME,. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24: 324-33.
20. Fekety R,. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 739-50.
21. Khanna S, Aronson SL, Kammer PP, Baddour LM, Pardi DS,. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study. Mayo Clin Proc 2012; 87: 636-42.
22. Tal S, Gurevich A, Guller V, Gurevich I, Berger D, Levi S,. Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly. Scand J Infect Dis 2002; 34: 594-7.